NorDiag Completes Merger with Genpoint Subsidiary | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Norwegian sample preparation firm NorDiag today said it has completed its merger with wholly owned subsidiary Genpoint.

The merger was announced in May as a way to reduce costs to both companies. As part of the transaction, all Genpoint employees are being offered employment with NorDiag, which acquired Genpoint in 2007.

The transaction was carried out with accounting and taxation effect from January 2010, NorDiag said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.